Subscribe to Newsletter

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Content by Stephanie Vine:

Business & Regulation Standards & Regulation

The Choice: To Be Cured or to Have Children?

| Stephanie Vine

Fertility support programs for gene therapy Medicare patients are being blocked in the US.

Manufacture Advanced Medicine

TILs Taking on Solid Tumors

| Stephanie Vine | 10 min read

An interview on the development of Amtagvi – the world’s first approved T-cell therapy for a solid tumor.

Business & Regulation Trends & Forecasts

Dystopia or Utopia? Contribute to our Special Feature on the Future of Pharma

| Stephanie Vine | 4 min read

Contribute to our special feature celebrating the future of pharma.

Discovery & Development Drug Discovery

Targeting Tau

| Stephanie Vine | 5 min read

How researchers are using mRNA to help untangle Alzheimer’s disease.

Manufacture Contract Manufacturing Services

Wegovy and Ozempic: Shortages, CDMO Controversy… And Bernie Sanders

| Stephanie Vine | 5 min read

Why GLP-1 anti-obesity drugs are taking the market by storm.

Discovery & Development Drug Discovery

APIs from the Algorithm

| Stephanie Vine | 2 min read

DRAGONFLY deep learning meets de novo drug design – and Roche has already tested the approach

Discovery & Development Drug Discovery

ADCs Versus Solid Tumors

| Stephanie Vine | 3 min read

Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

Manufacture Digital Technologies

A Smart Approach to Product Demos

| Stephanie Vine | 3 min read

Sending out instrumentation to trade shows or customer locations for demonstration purposes is expensive and not risk free. Enter 3D virtual worlds.

Discovery & Development Drug Discovery

Understanding Drug Development for Women

| Stephanie Vine | 3 min read

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Business & Regulation Standards & Regulation

Saying Farewell to the Famous Horse Tweet

| Stephanie Vine | 5 min read

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register